- CA$0.51m
- CA$14.38m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 1.1 | 0.04 | 0.08 | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Elixxer Ltd. is a Canada-based investment company. The Company has investments and activities in the legal cannabis sector. The Company is focused on investing opportunities in various sectors, with a priority on growth companies that are past the start-up phase.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- July 9th, 2004
- Public Since
- November 24th, 2005
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
TSX Venture Exchange- Shares in Issue
- 11,338,887
- Address
- Royal Bank Plaza South Tower, TORONTO, M5J2J1
- Web
- https://www.elixxer.com/
- Phone
- +1 5143977400
- Auditors
- CAN parteners LLP
Upcoming Events for ELXR.H
Q4 2025 Elixxer Ltd Earnings Release
Q1 2026 Elixxer Ltd Earnings Release
Similar to ELXR.H
DGTL Holdings
TSX Venture Exchange
GCC Global Capital
TSX Venture Exchange
iMining Technologies
TSX Venture Exchange
Manitex Capital
TSX Venture Exchange
Monitor Ventures
TSX Venture Exchange
FAQ
What is the Elixxer share price?
As of Today at 19:25 UTC, shares in Elixxer are trading at CA$0.05. This share price information is delayed by 15 minutes.
How has the Elixxer share price performed this year?
Shares in Elixxer last closed at CA$0.05 and the price had moved by -96.09% over the past 365 days. In terms of relative price strength the Elixxer share price has underperformed the Toronto Stock Exchange 300 Composite Index by -96.93% over the past year.
What are the analyst and broker recommendations for Elixxer?
There is no consensus recommendation for this security.
Find out moreWhat is the Elixxer dividend yield?
Elixxer does not currently pay a dividend.
Does Elixxer pay a dividend?
Elixxer does not currently pay a dividend.
When does Elixxer next pay dividends?
Elixxer does not currently pay a dividend.
How do I buy Elixxer shares?
To buy shares in Elixxer you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Elixxer?
As of the previous close price of CA$0.05, shares in Elixxer had a market capitalisation of CA$0.51m.
Where are Elixxer shares listed?
Here are the trading details for Elixxer:
- Country of listing: Canada
- Exchange: NEX
- Ticker Symbol: ELXR.H
What kind of share is Elixxer?
Based on an overall assessment of its quality, value and momentum Elixxer is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Elixxer share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Elixxer share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elixxer. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -70.39%.
As of the last closing price of CA$0.05, shares in Elixxer were trading -95.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Elixxer PE Ratio?
The Elixxer PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Elixxer?
Elixxer's management team is headed by:
- Ferras Zalt - CHM
- Kym No - CFO
- Tarik Alhaidary - DRC
- Jeff Cheah - IND
- Rafi Hazan - IND